Closed-loop optimization of chromatography column sizing strategies in biopharmaceutical manufacture

BACKGROUND This paper considers a real-world optimization problem involving the identification of cost-effective equipment sizing strategies for the sequence of chromatography steps employed to purify biopharmaceuticals. Tackling this problem requires solving a combinatorial optimization problem subject to multiple constraints, uncertain parameters, and time-consuming fitness evaluations. RESULTS An industrially-relevant case study is used to illustrate that evolutionary algorithms can identify chromatography sizing strategies with significant improvements in performance criteria related to process cost, time and product waste over the base case. The results demonstrate also that evolutionary algorithms perform best when infeasible solutions are repaired intelligently, the population size is set appropriately, and elitism is combined with a low number of Monte Carlo trials (needed to account for uncertainty). Adopting this setup turns out to be more important for scenarios where less time is available for the purification process. Finally, a data-visualization tool is employed to illustrate how user preferences can be accounted for when it comes to selecting a sizing strategy to be implemented in a real industrial setting. CONCLUSION This work demonstrates that closed-loop evolutionary optimization, when tuned properly and combined with a detailed manufacturing cost model, acts as a powerful decisional tool for the identification of cost-effective purification strategies. © 2013 The Authors. Journal of Chemical Technology & Biotechnology published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.

[1]  Nigel J. Titchener-Hooker,et al.  A framework for assessing the solutions in chromatographic process design and operation for large-scale manufacture , 2006 .

[2]  Ying Gao,et al.  Designing multi-product biopharmaceutical facilities using evolutionary algorithms , 2011 .

[3]  George E. P. Box,et al.  Evolutionary Operation: a Method for Increasing Industrial Productivity , 1957 .

[4]  Ingo Rechenberg,et al.  Case studies in evolutionary experimentation and computation , 2000 .

[5]  Suzanne S Farid,et al.  Strategic Biopharmaceutical Portfolio Development: An Analysis of Constraint‐Induced Implications , 2008, Biotechnology progress.

[6]  M. Friedman.  The Use of Ranks to Avoid the Assumption of Normality Implicit in the Analysis of Variance , 1937 .

[7]  C. Sivapathasekaran,et al.  Performance evaluation of an ANN–GA aided experimental modeling and optimization procedure for enhanced synthesis of marine biosurfactant in a stirred tank reactor , 2013 .

[8]  Duncan Low,et al.  Future of antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  Richard Allmendinger,et al.  Tuning evolutionary search for closed-loop optimization , 2012 .

[10]  Suzanne S. Farid,et al.  Dynamic Simulation Framework for Design of Lean Biopharmaceutical Manufacturing Operations , 2009 .

[11]  John H. Holland,et al.  Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence , 1992 .

[12]  D. Cliff,et al.  NKalpha: Non-uniform epistatic interactions in an extended NK model , 2008 .

[13]  Lazaros G. Papageorgiou,et al.  Mixed integer optimisation of antibody purification processes , 2013 .

[14]  Joshua D. Knowles,et al.  Efficient discovery of anti-inflammatory small molecule combinations using evolutionary computing , 2011, Nature chemical biology.

[15]  D. Kell,et al.  Explanatory optimization of protein mass spectrometry via genetic search. , 2003, Analytical chemistry.

[16]  H. Rabitz,et al.  Teaching lasers to control molecules. , 1992, Physical review letters.

[17]  Joshua D. Knowles.  Closed-loop evolutionary multiobjective optimization , 2009, IEEE Computational Intelligence Magazine.

[18]  Suzanne S. Farid,et al.  Stochastic Combinatorial Optimization Approach to Biopharmaceutical Portfolio Management , 2008 .

[19]  Sunil Chhatre,et al.  Decision‐Support Software for the Industrial‐Scale Chromatographic Purification of Antibodies , 2007, Biotechnology progress.

[20]  Suzanne S. Farid PhD Senior,et al.  Chapter 12. Process Economic Drivers in Industrial Monoclonal Antibody Manufacture , 2008 .

[21]  Songsong Liu,et al.  Designing cost‐effective biopharmaceutical facilities using mixed‐integer optimization , 2013, Biotechnology progress.

[22]  Suzanne S. Farid,et al.  Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma , 2007, Comput. Chem. Eng..

[23]  Eva Sorensen,et al.  Simultaneous optimal configuration, design and operation of batch distillation , 2005 .

[24]  Brian Kelley,et al.  Industrialization of mAb production technology: The bioprocessing industry at a crossroads , 2009, mAbs.

[25]  C. Wandrey,et al.  Use of a genetic algorithm in the development of a synthetic growth medium for Arthrobacter simplex with high hydrocortisone Δ1-dehydrogenase activity , 1995 .

[26]  Brian Kelley,et al.  Very Large Scale Monoclonal Antibody Purification: The Case for Conventional Unit Operations , 2007, Biotechnology progress.

[27]  Mark A. Bedau,et al.  Automated Discovery of Novel Drug Formulations Using Predictive Iterated High Throughput Experimentation , 2010, PloS one.

[28]  Suzanne S. Farid,et al.  A multi-level meta-heuristic algorithm for the optimisation of antibody purification processes , 2012 .

[29]  Dave Cliff,et al.  NKα - Non-uniform epistatic interactions in an extended NK model , 2008, ALIFE.

[30]  Suzanne S. Farid,et al.  Process Economic Drivers in Industrial Monoclonal Antibody Manufacture , 2008 .

[31]  Joshua D. Knowles,et al.  Closed-loop, multiobjective optimization of analytical instrumentation: gas chromatography/time-of-flight mass spectrometry of the metabolomes of human serum and of yeast fermentations. , 2005, Analytical chemistry.